Companies /Healthcare

Quantum-Si Incorporated - Class A

NASDAQ: QSI Medical Devices
$1.06
▼ $0.09 (−7.83%) today
Markets closed · 2:30am ET

QSI at a Glance

Valuation
Market cap
$252.7M
Profitability
Revenue (TTM)
$1.3M
EPS (TTM)
$-0.38
Price
52-week range
$1 – $2
Street target
$2.28

Headquartered in Branford, CT Fiscal year ends December NASDAQ: QSI quantum-si.com

About Quantum-Si

Quantum-Si Incorporated is a proteomics technology company developing benchtop instruments for single-molecule protein sequencing and analysis. Its platform uses real-time, kinetic-based detection so researchers can bypass traditional multistep workflows and directly study dynamic, functional protein characteristics. The company earns revenue from sales of instruments and consumable kits (product revenue) and from related services. Its current commercial products are the Platinum and Platinum Pro sequencing instruments and kits. The company is moving its customer base to the next-generation Proteus platform, with commercial launch expected in the second quarter of 2027 and a pre-order program already open. Proteus development includes amino acid recognizer expansion (19 of 20 amino acids detected), library preparation technology, and AI-enabled data analysis. The company is controlling costs through an August 2026 reduction in force affecting about 20% of headcount, while investing in manufacturing readiness, supply chain resilience and commercial launch preparation. Its Class A common stock trades on Nasdaq under the ticker QSI. Updated

QSI Coverage

11:15am ET
Investing

Quantum-Si (QSI) Earnings Coverage: Complete 1Q Coverage

Live Updates First earnings reaction4:30pm ETFirst reaction to QSIs earnings: 1. Product traction:Platinum Pro officially launched and shipped, but no units/revenue per customer disclosed. Adoption remains early-stage. 2. Burn rate update:Q1 net…

QSI
Joel South

Frequently Asked Questions

What does Quantum-Si do?

Quantum-Si Incorporated is a proteomics technology company developing benchtop instruments for single-molecule protein sequencing and analysis. Its platform uses real-time, kinetic-based detection so researchers can bypass traditional multistep workflows and directly study dynamic, functional protein characteristics.

What is the QSI stock price target?

The Wall Street consensus 12-month price target for QSI is $2.28.